|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
3
Amgen Acquires UK Biotech Dark Blue Therapeutics
4
The Benefits of an Immune-Directed ADC Strategy
5
